Introduction
============

Retinal angiogenesis is a complex process which involves cell-cell and cell-matrix interactions. Any abnormality affecting the retinal vasculature during development or at later stages of life will lead to severe pathologies resulting in blindness. For example, retinopathy of prematurity (ROP) is a retinal vasculature associated pathology occurring in premature infants, proliferative diabetic retinopathy (PDR) occurs in working age adults and wet age-related macular degeneration (AMD) affects older adults.[@b1-JOVR-07-316]-[@b4-JOVR-07-316]

Together, these retinal vasculature associated pathologies are major causes of global blindness. To treat or to find a novel target for these complex pathologies it is necessary to carefully understand both cell intrinsic and extrinsic players which regulate the development and function of retinal blood vessels. The goal of this review is to summarize the role of extracellular matrix (ECM)-cell interactions during development and their contribution to the pathobiologic events of neovascularization, and to identify potential therapeutic candidates to control disease progression. We will limit this discussion to intra-retinal events leaving aside for the most part issues related to choroidal neovascularization.

Embryonic Blood Supply
======================

Early in development, the inner portion of the eye is nourished by the hyaloid vascular system (HVS) which is a transient intraocular arterial supply attached to the posterior pole of the lens.[@b5-JOVR-07-316] After birth, myeloid cells mediate gradual regression of the HVS.[@b6-JOVR-07-316],[@b7-JOVR-07-316] In human disease conditions such as ROP, familial exudative vitreoretinopathy and Pearson's syndrome, regression of the HVS is altered, resulting in persistent hyaloid vessels.[@b8-JOVR-07-316]-[@b10-JOVR-07-316] Mouse models in which various laminin chains are deleted also show persistent hyaloid vessels, as do mouse mutants in which laminin binding is disrupted and also with other basement membrane mutants.[@b11-JOVR-07-316]-[@b15-JOVR-07-316]

Regulation of hyaloid vessel regression by laminins is mediated via integrin a6b1. Integrin activation results in changes in chemokines such as tumor necrosis factor (TNF), interferon (IFN)-a, and IFN-g and these chemokines in turn may interact with microglia.[@b16-JOVR-07-316] Hence, the effects of laminin deletion are probably the result of failure to activate or recruit microglia during hyaloid vessel regression. It is of interest to analyze clinical samples where persistent fetal vessels are observed for alterations in ECM pathways, particularly integrin-mediated pathways. If these pathways are deficient, it may then be possible to transiently activate microglia to promote HSV regression.

Retinal Vascular Development
============================

The retinal vascular system consists of three interconnected vascular layers: superficial, intermediate and deep. Development of the superficial layer is the initial step in retinal angiogenesis and is dependent on astrocytes.[@b5-JOVR-07-316] Once the superficial vasculature reaches the periphery of the retina, the deep and intermediate plexiform layers are formed; Muller cells regulate these later stages of retinal vascularization[@b17-JOVR-07-316] ([Fig. 1](#f1-JOVR-07-316){ref-type="fig"}).

Astrocyte Migration into the Retina
===================================

Astrocytes are star-shaped glial cells that regulate a wide variety of functions in the central nervous system.[@b19-JOVR-07-316] One of their most well-characterized functions is the regulation of retinal angiogenesis and participation in the blood-retinal barrier[@b20-JOVR-07-316] ([Fig. 2](#f2-JOVR-07-316){ref-type="fig"}A). Retinas are only vascularized in mammalians in the presence of retinal astrocytes. Retinas lacking astrocytes remain avascular and those in which astrocyte distribution is limited have spatially limited vascular development. For example, in adult possums, astrocytes are distributed only around the optic disc and the optic disc remains the only vascularized region of the possum retina.[@b21-JOVR-07-316] In human and non-human primate retinas, the avascular foveal region also lacks astrocytes.[@b22-JOVR-07-316],[@b23-JOVR-07-316] These data suggest that retinal blood vessel formation is strictly dependent upon astrocytes.

Retinal astrocytes are generated from astrocyte precursor cells outside the retina in the optic nerve. The astrocyte precursors express Pax-2 transcription factor which is critical for astrocyte determination and differentiation.[@b24-JOVR-07-316]-[@b27-JOVR-07-316] In order to populate the retina, differentiating astrocytes enter the retina through the optic nerve head and migrate over the vitreal surface.[@b28-JOVR-07-316]

Astrocytes invade the mouse retina around embryonic days 17-18[@b24-JOVR-07-316],[@b29-JOVR-07-316] ([Fig. 1](#f1-JOVR-07-316){ref-type="fig"}). Upon entering the retina, a proliferating population of astrocytes spreads toward the periphery in a centrifugal fashion.[@b5-JOVR-07-316] The proliferation of astrocytes during this migration is regulated by platelet-derived growth factor (PDGF)-A secreted by ganglion cells.[@b5-JOVR-07-316],[@b30-JOVR-07-316] Overexpression of PDGF-A or neutralization of the PDGF receptor, PDGFR-a, affects astrocyte proliferation and network formation.[@b30-JOVR-07-316] These observations demonstrate that PDGF-A signaling is crucial for astrocyte proliferation.

In addition, the mouse homolog of drosophila tailless, Tlx (Nr2e1), is critical for astrocyte morphogenesis. Mice lacking the Tlx gene display abnormal astrocyte morphology, poor astrocyte scaffold formation and complete failure of assembly in the extracellular matrix.[@b31-JOVR-07-316],[@b32-JOVR-07-316] Although these studies have provided valuable information regarding the regulation of astrocyte proliferation and differentiation, factors that guide astrocytes into the retina remain unknown.

Regulation of Astrocyte Migration by Laminins
=============================================

Basement membranes (BM) are acellular extracellular matrices which separate tissue compartments and serve as key regulators of differentiation and migration in a variety of tissues including the retina. Classically these structures are composed of laminin, collagen type IV, nidogen and heparin sulfate protoglycans.[@b33-JOVR-07-316] Laminin deposition is the primary and key step in BM formation; the laminin family is a relatively small group of heterotrimeric glycoproteins. A laminin isoform is composed of an a chain, a b chain, and a g chain. There are 5 a, 3 b and 3 g chains identified and a total of 16 laminin isoforms have been isolated and confirmed so far.[@b33-JOVR-07-316] Interactions between laminins and integrins are isoform specific and regulate migration of a variety of cells in different tissues including the retina.[@b33-JOVR-07-316]-[@b36-JOVR-07-316] The specificity of laminin's biological activity is presumed to arise from its differential expression: spatially, in adult tissues and temporally, during development.

Our studies have shown that deletion of the *Lamb2* gene (encoding the laminin b2 chain) alone, as well as in combination with the *Lamc3* gene (encoding the laminin g3 chain), affects the assembly of one BM in the retina, the inner limiting membrane (ILM).[@b37-JOVR-07-316] Importantly, deletion of these laminin genes, singly or in combination also affects astrocyte migration and patterning[@b12-JOVR-07-316] (compare [Figures 2](#f2-JOVR-07-316){ref-type="fig"}A and [2](#f2-JOVR-07-316){ref-type="fig"}B). A similar defect in astrocyte patterning and vascular growth is present in *Lama1* gene (encoding the laminin a1 chain) mutant retinas.[@b11-JOVR-07-316] These results suggest that laminins in the ILM guide and regulate astrocyte migration. This hypothesis is supported by several *ex vivo* experiments. Specifically, the addition of exogenous laminin onto the retinal surface of cultured *Lamb2:c3* compound null retina rescued both astrocyte migration and spatial patterning.[@b12-JOVR-07-316] Astrocyte spatial patterning is critical for subsequent vascular growth because the astrocyte-derived template guides endothelial migration and patterning.[@b18-JOVR-07-316],[@b32-JOVR-07-316],[@b38-JOVR-07-316],[@b39-JOVR-07-316]

Tip Cell Selection and Endothelial Cell Migration
=================================================

It has been suggested that the astrocyte template secretes a fibronectin-rich matrix, which sequesters vascular endothelial growth factor (VEGF) and subsequently guides endothelial cells.[@b18-JOVR-07-316],[@b32-JOVR-07-316] However, astrocyte-specific deletion of fibronectin only delays vascular growth progression and does not completely abolish endothelial growth suggesting that astrocyte-derived fibronectin is not necessary for endothelial development.[@b40-JOVR-07-316] A critical role for other matrix molecules is likely since the canonical matrix receptors, integrin b1, is expressed by endothelial cells and they have been shown to regulate vascular growth and branching.[@b41-JOVR-07-316],[@b42-JOVR-07-316] Given the data discussed above regarding laminins and the fact that b1 integrins are strong laminin binding molecules, there is little doubt that interaction between ligand (laminin) and receptor (integrins) play a key step in endothelial patterning and constitute an attractive therapeutic target.

The elongating vascular tube consists of two endothelial cell types: leading tip cells perform sensory function responding to cues, and the lagging stalk cells form the more stable vessel wall. Thus, regulation of the number and behavior of both tip and stalk cells determine the rate of vascular growth and the density of branching. Initially, the formation of tip cells is induced by astrocyte-derived VEGF-A gradient. These tip cells express the VEGF receptor (VEGFR)-2,[@b18-JOVR-07-316] which allows tip cells to respond to the astrocyte-derived VEGF-A gradient. In addition to this VEGF-A-VEGFR2 signaling pathway, the VEGF-C-VEGR3 pathway also regulates tip-stalk cell formation in the retina.[@b43-JOVR-07-316],[@b44-JOVR-07-316]

Vascular density is regulated by regulating tip cell production; specifically the number of tip cells determines branching points in the elongating vessel. Tip cell selection is regulated by a notch-delta like ligand-4 (Dll4) signaling mechanism.[@b45-JOVR-07-316],[@b46-JOVR-07-316] Deletion of one of the alleles for Dll4 and endothelial specific deletion of notch-1 increases tip cell number.[@b45-JOVR-07-316] Together, these results suggest that activation of the notch-Dll4 pathway is critical for controlled vascular growth. Moreover, laminin-integrin mediated signaling is thought to modulate endothelial tip cell selection through a notch- Dll4 signalling pathway suggesting that the matrix plays an important role in modifying vascular patterning and thereby density.[@b47-JOVR-07-316]

In summary, communication between cell extrinsic and intrinsic molecules is necessary to achieve proper vascular growth and patterning. An imbalance in the interactions between cell extrinsic and intrinsic signaling will affect vascular development. Moreover, it is likely that neovascularization events are the result of disruptions anywhere in these pathways. Thus, the most effective treatment of vascular related pathologies will result from careful manipulation of the complex signaling pathways involved. The role of the clinician scientist will be to carefully define the etiology of the vascular defects and construct a rational therapeutic strategy.

Vascular Specification and Branching
====================================

Other critical events that occur during vascular growth progression include specification of arteries and veins, and their branching. The exact mechanism by which some endothelial cells take up arterial and venous fate is not completely understood. However, it has been suggested that ephrins and Eph receptors play important roles. The differential expression of ephrin-B2 ligand and the EphB4 receptor segregate endothelial cells from each other. The endothelial cells in arteries express ephrin-B2, whereas endothelial cells in veins express EphB4.[@b29-JOVR-07-316],[@b48-JOVR-07-316],[@b49-JOVR-07-316] These data suggest that specific ephrins including ephrin-B2 play a role in specifying arterial fate, and specific Ephs including EphB4 play a role in specifying venous fate.

The combinatorial action of the specific VEGF-A isoforms 188, 164, and 120 also regulates vascular specification and branching.[@b50-JOVR-07-316],[@b51-JOVR-07-316] For instance, mice solely expressing the heparan sulfate binding isoform, VEGF188 (VEGF^188/188^), show excessive branching and impaired arterial specification.[@b51-JOVR-07-316] On the other hand, mice expressing only the diffusible VEGF120 (VEGF^120/120^) show severe defects in vascular branching as well as impairment of arterial specification.[@b50-JOVR-07-316],[@b51-JOVR-07-316] The hypothesis is that matrix bound VEGF serves to orient tip cell extension and thereby vascular branching; the loss of the matrix bound form disorients this process. Importantly, when VEGF188 was ectopically expressed, in VEGF^120/120^ animals, vascular defects were rescued.[@b50-JOVR-07-316] Mice expressing only VEGF164, which has both diffusible and heparan sulfate binding characteristics, display no vascular branching or specification defects.[@b51-JOVR-07-316] Taken together, these findings suggest that both matrix-bound and diffusible VEGFs are required for vascular growth progression, specification and branching.

Recruitment of Smooth Muscle Actin Expressing Cells and Blood Vessel Maturation
===============================================================================

Vessel branching and elongation are initial stages of angiogenesis, following this step the vessel wall must become stabilized. This stabilization is achieved during vascular growth when endothelial cells attract a class of actin-expressing smooth muscle cells (SMCs), the pericyte, into the vascular wall. Endothelial cells are thought to secret PDGF-B, the incorporation of pericytes as mural cells leads to stabilization of the vascular basement membrane and subsequently the vascular wall.[@b28-JOVR-07-316] Intraperitoneal injection of monoclonal antibodies directed against PDGFR-b affects pericyte recruitment and blood vessel integrity, leading to vascular leakage.[@b52-JOVR-07-316]

Migration of SMCs over the vascular wall is modulated by interactions between the cellular environment and cell surface receptors including integrins containing the integrin b1 subunit.[@b52-JOVR-07-316] For example, cell specific deletion of integrin b1 affects SMC migration and integration into the vascular wall which destabilizes overall vascular integrity[@b53-JOVR-07-316] ([Fig. 3](#f3-JOVR-07-316){ref-type="fig"}A). Once SMCs are recruited into the vascular wall, they in turn secrete stabilizing factors such as angiopoetin-1 (Ang-1) and transforming growth factor-b (TGF-b). Both Ang-1 and TBG-b are critical for endothelial stabilization of the vascular wall including deposition of basement membrane molecules over the vascular wall[@b52-JOVR-07-316],[@b54-JOVR-07-316],[@b55-JOVR-07-316] ([Figures 3](#f3-JOVR-07-316){ref-type="fig"}A, [3](#f3-JOVR-07-316){ref-type="fig"}C and [@b3-JOVR-07-316]D). Thus, interaction of SMCs with the vascular wall is critical for vascular stability.

Moreover, the loss of mural cells such as the pericyte is a key step in destabilizing an existing vessel. Interference with pericyte mural adhesion results in the death of the pericyte by anoikis.[@b56-JOVR-07-316] Studies have suggested that manipulation of mural cell-ECM interactions is likely to be important therapeutically.[@b57-JOVR-07-316],[@b58-JOVR-07-316]

Formation of Deeper Vascular Plexus
===================================

After the formation of the superficial vascular plexus is complete, deep and intermediate vascular plexiform layers start to develop. The development of these layers is complete at approximately postnatal day 15 in mice. These differentiation events occur through several signaling pathways, including those involving Wnts and VEGF.[@b17-JOVR-07-316],[@b59-JOVR-07-316]

Wnts expressed by microglia suppress excessive vascular branching through non-canonical Wnt-Flt1 pathway. Microglial specific deletion of the Wnt ligand transporter, Wntless, results in excessive vascular branching in the deep vascular layer.[@b59-JOVR-07-316] Thus, the Wnt pathway is a component during formation of the deep vascular plexus.

The high metabolic demand caused by maturation of cells in the outer retina (particularly with the onset of functional synapses) causes Müller cells to secrete VEGF.[@b5-JOVR-07-316],[@b17-JOVR-07-316] In response to this burst of extracellular VEGF, endothelial cells of veins and venules in the superficial vascular layer extend along Müller cell processes and form the deep and intermediate vascular layers5 ([Fig. 1](#f1-JOVR-07-316){ref-type="fig"}). Unlike superficial capillary branching which was regulated by astrocyte-endothelial interactions, during the formation of these deeper beds, microglial cells regulate vascular branching of deep and intermediate vascular layers.[@b59-JOVR-07-316] Studies on the formation of the deep vascular plexus have provided valuable insight into vascular regulation, but further studies are required to reveal the role of other factors such as delta and notch signaling in this process.

Overall, a major question is how to tackle the complex process of vascular remodeling under pathological conditions, i.e., during neovascularization. As demonstrated above, the molecular processes of angiogenesis during development respond to environmental factors such as metabolic demand to increase vascular supply. These mechanisms remain active throughout adulthood, albeit without the temporal regulation exerted during normal development.

One of the leading causes of neovascularization is hypoxia-driven VEGF expression. Hypoxia-induced, VEGF-mediated signaling promotes abnormal new blood vessel formation.[@b1-JOVR-07-316] However, anti-VEGF therapy may not be appropriate for all conditions, because VEGF-A is an important factor for neuronal survival under ischemia;[@b60-JOVR-07-316] this matter is likely to be particularly important in the premature infant. Thus, finding new targets to stabilize the vasculature would generate a better method to treat pathological neovascularization. The cell-matrix interface is a profoundly important target. Recent studies have reported abnormalities at the cell-matrix interface during pathological conditions (summarized below) and indeed some initial steps have been made in using mural cell-ECM interactions as therapies (above). These successes provide an impetus for further therapeutic developments.

Changes in Cell-Matrix Interactions During Retinal Vasculature Pathologies related to Retinopathy of Prematurity
================================================================================================================

ROP occurs in two phases: in the first phase, vascular growth becomes attenuated; in the second phase, neovascular sprouts develop in response to VEGF secretion.[@b1-JOVR-07-316] Both phases are likely dependent on cell-matrix interactions. Blood vessel growth in the peripheral retina is severely affected in infants with ROP ([Fig. 2](#f2-JOVR-07-316){ref-type="fig"}C).[@b3-JOVR-07-316] This defective growth could be a result of defective astrocyte migration and template formation in the peripheral retina. As detailed above the template on which astrocytes migrate ([Fig. 2](#f2-JOVR-07-316){ref-type="fig"}A) and vessels form is comprised, in part, of laminins. Deletion of laminin chains contributes to defective astrocyte patterning and blood vessel formation.[@b11-JOVR-07-316],[@b12-JOVR-07-316] Astrocyte distribution is severely affected in *Lamb2* null retinas (data not shown) and *Lamb2:c3* double null retinas ([Fig. 2](#f2-JOVR-07-316){ref-type="fig"}B). This disruption of astrocyte distribution in laminin null animals is particularly marked in peripheral regions of the retina, where there is poor or no blood vessel formation.[@b12-JOVR-07-316] In addition, infants with ROP also show signs of vascular leakage ([Fig. 3](#f3-JOVR-07-316){ref-type="fig"}B),[@b9-JOVR-07-316] a feature shared with *Lamb2* nulls and *Lamb2:c3* double null retinas ([Figures 3](#f3-JOVR-07-316){ref-type="fig"}C and 3D; control [figure 3](#f3-JOVR-07-316){ref-type="fig"}A). Because of this similarity, it is of interest to analyze whether the expression and distribution of laminins are affected in ROP models. If there were a loss of laminins in ROP models, rescue of laminin expression may help astrocytes to migrate and pattern properly. This rescue would then allow endothelial cells to re-vascularize in a normal fashion.

The defective vascular growth observed in infants with ROP could also be due to degeneration of astrocytes under hyper/hypoxic conditions. In experimental animal models, astrocytes degenerate under hypoxic conditions.[@b63-JOVR-07-316],[@b64-JOVR-07-316] In addition, brain derived astrocytes lose integrin (a1, a6, b1) and dystroglycan receptors under ischemic conditions.[@b65-JOVR-07-316],[@b66-JOVR-07-316]

It is likely that loss of contact with BM causes astrocyte degeneration in ROP. It is also possible that remodeling of BM during cyclic oxygen conditions affects the astrocyte-BM interaction resulting in cell death, because hypoxia has shown to activate matrix metalloproteinases (MMPs). Activation of MMPs affects cellular interaction and causes vascular leakage.[@b67-JOVR-07-316] Maintaining the astrocyte population under hypoxic conditions reduces neovascularization.[@b63-JOVR-07-316] Thus, it is possible that stabilizing astrocyte and endothelial interactions with the BM might reduce the risk of neovascularization in ROP.

Changes in Cell-Matrix Interactions in Diabetic Retinopathy
===========================================================

One of the key clinical features of diabetic retinopathy is BM thickening, with a marked increase in collagen IV deposition.[@b68-JOVR-07-316] Rat models of diabetic retinopathy also have increased levels of fibronectin and experimental down-regulation of fibronectin in these models improves vascular lesions.[@b69-JOVR-07-316] Moreover, laminin b2 chain synthesis is decreased by elevated glucose in both experimental animal models and in vitro studies on the kidney.[@b70-JOVR-07-316],[@b71-JOVR-07-316]

Laminins are critical for astrocyte and Müller cell interaction with the ILM in the retina.[@b12-JOVR-07-316],[@b72-JOVR-07-316] In addition, mutations in the LAMB2 gene lead to Pierson syndrome[@b8-JOVR-07-316],[@b73-JOVR-07-316] and animals with mutations in this gene phenocopy many aspects of the human disease.[@b36-JOVR-07-316],[@b74-JOVR-07-316] It will be of interest to analyze whether the expression of collagens, fibronectin and laminins are altered in the hyperglycemic retina, as hyperglycemia has been shown to cause astrocyte degeneration and induce glial fibrillary acidic protein (GFAP) expression in Müller cells, which is suggestive of reactive gliosis ([Fig. 4](#f4-JOVR-07-316){ref-type="fig"}).[@b62-JOVR-07-316],[@b75-JOVR-07-316] These abnormalities in glial cells could be due to remodelling of the matrix or result from changes involving cell surface receptors. In addition to changes in glial cells, hyperglycemia also causes loss of mural pericytes, which leads to mural instability, vascular leakage and subsequent neovascularization.[@b76-JOVR-07-316],[@b77-JOVR-07-316] As noted above, mural cell adhesion to the vascular wall is mediated through integrins.[@b53-JOVR-07-316]

In conclusion, the data above suggest that coordinated signaling between cell extrinsic ECM molecules and cell intrinsic molecules are necessary for proper retinal vascular development and function. Experimental animal models of ischemia and PDR suggest that the first insult occurs at the mural cell-ECM interface. Therefore, a careful proteomic study accompanied with a microarray analysis will better clarify changes taking place with BM molecules and their interacting cell surface receptors in experimental ROP and diabetic retinopathy models. In addition, the results of these analyses may contribute to the discovery of additional ways to stabilize cell surface receptor interactions with BM molecules, which will ultimately prevent cell death in the retina and reduce neovascularization.
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![Astrocytes and Müller cells guide endothelial cells. (A) At postnatal day 1 (P1), astrocytes (yellow) migrate into the retina through the optic nerve head and make a template over which endothelial cells migrate. (B) By postnatal day 5 (P5), endothelial cells cover more than half of the retinal surface. (C) By postnatal day 8 (P8), superficial blood vessel formation is completed. At this point, Müller cells (green) attract the endothelial cells which start to form deep and intermediate vascular layers. This process is completed around postnatal day 15 (not shown). \[Modified from Gerhardt et al, 2003. Originally published in *The Journal of Cell Biology;* doi: 10.1083/jcb.200302047\][@b18-JOVR-07-316]](JOVR-07-316f1){#f1-JOVR-07-316}

![Vascular growth in peripheral retina is affected in laminin nulls as well as infants with retinopathy of prematurity (ROP). \*(A) Postnatal day 15 wild type retina was immunostained for glial fibrillary acidic protein (GFAP) (green) to label astrocytes and CD31 (Red) to label blood vessels. \*(B) Postnatal day 15 Lamb2:c3 null retina was immunostained for GFAP (green) to label astrocytes and CD31 (Red) to label blood vessels. Notice abnormal astrocyte patterning and vascular growth. Astrocyte patterning and subsequent vascular growth was affected in the peripheral retina (black arrows). \*\*(C) Black arrows at the peripheral retina show no vascular growth in an infant with ROP. \*\[Data in A and B are from the author's laboratory\]. \*\*\[Reprinted by permission from Nature Publishing Group. Gariano and Gardner, 2005. Originally published in *Nature*; 438:960-966.\][@b3-JOVR-07-316]](JOVR-07-316f2){#f2-JOVR-07-316}

![Defective vascular integrity in laminin null retinas and advanced stage 4 retinopathy of prematurity (ROP). \*(A) Fluorescein angiography in wild type P15 mouse retina shows no signs of vascular leakage approximately 120 sec after intra-peritoneal injection of sodium fluorescein. \*\*(B) Advanced stage 4 ROP reveals hemorrhage (asterisk) and avascular peripheral retina (black arrows). \*(C) Fluorescein angiography in Lamb2 null retina shows vascular leakage approximately 120 sec after intra-peritoneal injection of sodium fluorescein (black arrow). \*(D) Fluorescein angiography in Lamb2:c3 null retina shows vascular leakage approximately 120 sec after intra-peritoneal injection of sodium fluorescein (black arrows). \*\[Data in A, C and D are from the author's laboratory\]. \*\*\[Reprinted with permission from the International Journal of Developmental Biology. Saint-Geniez and D'Amore, 2004. Originally published in Int *J Dev Biol*; 48:1045-1058\][@b61-JOVR-07-316]](JOVR-07-316f3){#f3-JOVR-07-316}

![Experimental rat model for diabetes shows loss of GFAP expression in astrocytes and reactive gliosis of Müller cells. (A) Control flat-mount retina showing glial fibrillary acidic protein (GFAP) expression in astrocytes. (B) Streptozotocin (STZ)-diabetic rats show loss of GFAP expression in astrocytes after 4 months of induction of diabetes. (C) Insulin treatment for 48 hr of STZ-diabetic rats shows partial recovery of GFAP expression in astrocytes. (D) Control rats show no GFAP immunoreactivity in Müller cells (image focused on the outer plexiform layer). (E) STZ-diabetic rats show GFAP expression in Müller cells after 4 months of induction of diabetes (image focused on the outer plexiform layer). (F) Insulin treatment for 48 hr of STZ-diabetic rats shows partial reduction of GFAP in Müller cells (image focused on the outer plexiform layer). \[Reprinted with permission from Association for Research in Vision and Ophthalmology as the copyright holder. Barber et al, 2000. Originally published in *Investigative Ophthalmology & Visual Science*; 4: 3561-3568\][@b62-JOVR-07-316]](JOVR-07-316f4){#f4-JOVR-07-316}
